Personalized (laboratory) medicine: A bridge to the future

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 4, 2013, Pages 703-706

  Plebani, Mario ^a   Lippi, Giuseppe ^b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Gender; Laboratory medicine; Personalized medicine; Reference range; Reference values

Indexed keywords

CARDIOVASCULAR RISK; GENDER; IMMUNOASSAY; LABORATORY DIAGNOSIS; MEDICAL PRACTICE; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; SCIENTIST; SCREENING;

CARDIOVASCULAR DISEASES; HUMANS; LIVER DISEASES; NEOPLASMS; OSTEOPOROSIS;

EID: 84882279024     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0021     Document Type: Review

References (20)

1. Lippi G, Plebani M, Guidi GC. The paradox in translational medicine. Clin Chem 2007;53:1553.
2. Khoury MJ. Dealing with the evidence dilemma in genomics and personalized medicine. Clin Pharmacol Ther 2010;87:635-8.
3. Redberg RF. Don ' t assume women are the same as men: include them in trial. Arch Intern Med 2012;172:921.
4. Baggio G, Corsini A, Floreani A, Giannini S, Zagonel V. Gender medicine: a task for the third millennium. Clin Chem Lab Med 2013;51:713-27.
5. Guidi GC, Lippi G, Solero GP, Poli G, Plebani M. Managing transferability of laboratory data. Clin Chim Acta 2006;374:57-62.
6. Siest G, Henny J, Gr ä sbeck R, Wilding P, Petitclerc C, Queralt ó JM, et al. The theory of reference values: an unfinished symphony. Clin Chem Lab Med 2013;51:47-64.
7. Plebani M, Lippi G. Reference values and the journal: why the past is now present. Clin Chem Lab Med 2012;50: 761-3.
8. Henny J. The IFCC recommendations for determining reference intervals: strengths and limitations. J Lab Med 2009;33: 45-51.
9. Clinical and Laboratory Standards Institute. Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline, 3rd ed. CLSI document C28-A3. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
10. Lippi G, Plebani M. Athlete ' s biological passport: to test or not to test? Clin Chem Lab Med 2011;49:1393-5.
11. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem 2012;58:1574-81.
12. Giannoni A, Giovannini S, Clerico A. Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal? Clin Chem Lab Med 2009;47:1167-77.
13. Lippi G, Cervellin G, Banfi G, Plebani M. Cardiac troponins and physical exercise. It ' s time to make a point. Biochem Med (Zagreb) 2011;21:55-62.
14. Lippi G, Schena F, Dipalo M, Montagnana M, Salvagno GL, Aloe R, et al. Troponin I measured with a high sensitivity immunoassay is significantly increased after a half marathon run. Scand J Clin Lab Invest 2012;72:467-70.
15. Lippi G, Cervellin G. Identification of troponin determinants for improving its diagnostic performance in the emergency department. J Emerg Med 2012;43:e487-8.
16. Melichar B. Tumor biomarkers: PSA and beyond. Clin Chem Lab Med 2012;50:1865-9.
17. Melichar B. Laboratory medicine and medical oncology: the tale of two Cinderellas. Clin Chem Lab Med 2013; 51:99-112.
18. Weinert LS, Camargo EG, Soares AA, Silveiro SP. Glomerular filtration rate estimation: performance of serum cystatin C-based prediction equations. Clin Chem Lab Med 2011;49:1761-71.
19. Hannemann A, Friedrich N, Dittmann K, Spielhagen C, Wallaschofski H, V ö lzke H, et al. Age- and sex-specific reference limits for creatinine, cystatin C and the estimated glomerular filtration rate. Clin Chem Lab Med 2011;50:919-26.
20. Soh TI, Yong WP, Innocenti F. Recent progress and clinical importance on pharmacogenetics in cancer therapy. Clin Chem Lab Med 2011;49:1621-32